Research
Print page Print page
Switch language
The Capital Region of Denmark - a part of Copenhagen University Hospital
Published

Home-based cognitive behavioural therapy for families of young children with cancer (FAMOS): A nationwide randomised controlled trial

Research output: Contribution to journalJournal articleResearchpeer-review

Harvard

Salem, H, Kazak, AE, Andersen, EW, Belmonte, F, Johansen, C, Schmiegelow, K, Winther, JF, Wehner, PS, Hasle, H, Rosthøj, S & Bidstrup, PE 2021, 'Home-based cognitive behavioural therapy for families of young children with cancer (FAMOS): A nationwide randomised controlled trial', Pediatric Blood & Cancer, vol. 68, no. 3, pp. e28853. https://doi.org/10.1002/pbc.28853

APA

Salem, H., Kazak, A. E., Andersen, E. W., Belmonte, F., Johansen, C., Schmiegelow, K., Winther, J. F., Wehner, P. S., Hasle, H., Rosthøj, S., & Bidstrup, P. E. (2021). Home-based cognitive behavioural therapy for families of young children with cancer (FAMOS): A nationwide randomised controlled trial. Pediatric Blood & Cancer, 68(3), e28853. https://doi.org/10.1002/pbc.28853

CBE

MLA

Vancouver

Author

Salem, Hanin ; Kazak, Anne E ; Andersen, Elisabeth Wreford ; Belmonte, Federica ; Johansen, Christoffer ; Schmiegelow, Kjeld ; Winther, Jeanette Falck ; Wehner, Peder Skov ; Hasle, Henrik ; Rosthøj, Steen ; Bidstrup, Pernille E. / Home-based cognitive behavioural therapy for families of young children with cancer (FAMOS) : A nationwide randomised controlled trial. In: Pediatric Blood & Cancer. 2021 ; Vol. 68, No. 3. pp. e28853.

Bibtex

@article{7cfb284d10e64238be249dc81b70cc32,
title = "Home-based cognitive behavioural therapy for families of young children with cancer (FAMOS): A nationwide randomised controlled trial",
abstract = "INTRODUCTION: Evidence-based knowledge is needed to reduce psychological symptoms in families of young children with cancer after treatment ends.OBJECTIVE: To evaluate the effect of a psychotherapeutic intervention, FAMily-Oriented Support (FAMOS) on parents of young children after cancer treatment.METHODS: All families of children aged 0-6 years who had been treated for cancer at one of the four paediatric oncology departments in Denmark were invited to participate after ending intensive medical treatment. The families were randomly assigned 1:1 to up to seven sessions of FAMOS, a cognitive-behavioural manualised home intervention, for 6 months or to usual psychosocial care. The primary outcome was parents' symptoms of posttraumatic stress disorder (PTSD) at 6 and 12 months after enrolment. The secondary outcomes were parents' symptoms of depression and anxiety.RESULTS: We enrolled 109 families (204 parents). Parents in the intervention group did not show a statistically significant decrease in symptoms of PTSD as compared with the control group at 6 months (predicted mean difference, -0.10; 95% confidence interval [CI] -0.19, 0.01), but a statistically significant decrease was seen at 12 months (predicted mean difference, -0.15; 95% CI -0.28, -0.02), and they had significantly lower symptoms of depression at both 6 and 12 months. Differences in reductions in symptoms of anxiety were not statistically significant.CONCLUSIONS: The FAMOS intervention reduced parents' symptoms of PTSD and depression. Next step is to also report on psychological effects in the children and siblings (clinicaltrials.gov: NCT02200731).",
keywords = "anxiety, cancer, cognitive behavioural psychotherapy, depression, family, posttraumatic stress disorder, randomised controlled trial",
author = "Hanin Salem and Kazak, {Anne E} and Andersen, {Elisabeth Wreford} and Federica Belmonte and Christoffer Johansen and Kjeld Schmiegelow and Winther, {Jeanette Falck} and Wehner, {Peder Skov} and Henrik Hasle and Steen Rosth{\o}j and Bidstrup, {Pernille E}",
note = "{\textcopyright} 2020 Wiley Periodicals LLC.",
year = "2021",
month = mar,
doi = "10.1002/pbc.28853",
language = "English",
volume = "68",
pages = "e28853",
journal = "Pediatric Blood and Cancer",
issn = "1545-5009",
publisher = "Wiley",
number = "3",

}

RIS

TY - JOUR

T1 - Home-based cognitive behavioural therapy for families of young children with cancer (FAMOS)

T2 - A nationwide randomised controlled trial

AU - Salem, Hanin

AU - Kazak, Anne E

AU - Andersen, Elisabeth Wreford

AU - Belmonte, Federica

AU - Johansen, Christoffer

AU - Schmiegelow, Kjeld

AU - Winther, Jeanette Falck

AU - Wehner, Peder Skov

AU - Hasle, Henrik

AU - Rosthøj, Steen

AU - Bidstrup, Pernille E

N1 - © 2020 Wiley Periodicals LLC.

PY - 2021/3

Y1 - 2021/3

N2 - INTRODUCTION: Evidence-based knowledge is needed to reduce psychological symptoms in families of young children with cancer after treatment ends.OBJECTIVE: To evaluate the effect of a psychotherapeutic intervention, FAMily-Oriented Support (FAMOS) on parents of young children after cancer treatment.METHODS: All families of children aged 0-6 years who had been treated for cancer at one of the four paediatric oncology departments in Denmark were invited to participate after ending intensive medical treatment. The families were randomly assigned 1:1 to up to seven sessions of FAMOS, a cognitive-behavioural manualised home intervention, for 6 months or to usual psychosocial care. The primary outcome was parents' symptoms of posttraumatic stress disorder (PTSD) at 6 and 12 months after enrolment. The secondary outcomes were parents' symptoms of depression and anxiety.RESULTS: We enrolled 109 families (204 parents). Parents in the intervention group did not show a statistically significant decrease in symptoms of PTSD as compared with the control group at 6 months (predicted mean difference, -0.10; 95% confidence interval [CI] -0.19, 0.01), but a statistically significant decrease was seen at 12 months (predicted mean difference, -0.15; 95% CI -0.28, -0.02), and they had significantly lower symptoms of depression at both 6 and 12 months. Differences in reductions in symptoms of anxiety were not statistically significant.CONCLUSIONS: The FAMOS intervention reduced parents' symptoms of PTSD and depression. Next step is to also report on psychological effects in the children and siblings (clinicaltrials.gov: NCT02200731).

AB - INTRODUCTION: Evidence-based knowledge is needed to reduce psychological symptoms in families of young children with cancer after treatment ends.OBJECTIVE: To evaluate the effect of a psychotherapeutic intervention, FAMily-Oriented Support (FAMOS) on parents of young children after cancer treatment.METHODS: All families of children aged 0-6 years who had been treated for cancer at one of the four paediatric oncology departments in Denmark were invited to participate after ending intensive medical treatment. The families were randomly assigned 1:1 to up to seven sessions of FAMOS, a cognitive-behavioural manualised home intervention, for 6 months or to usual psychosocial care. The primary outcome was parents' symptoms of posttraumatic stress disorder (PTSD) at 6 and 12 months after enrolment. The secondary outcomes were parents' symptoms of depression and anxiety.RESULTS: We enrolled 109 families (204 parents). Parents in the intervention group did not show a statistically significant decrease in symptoms of PTSD as compared with the control group at 6 months (predicted mean difference, -0.10; 95% confidence interval [CI] -0.19, 0.01), but a statistically significant decrease was seen at 12 months (predicted mean difference, -0.15; 95% CI -0.28, -0.02), and they had significantly lower symptoms of depression at both 6 and 12 months. Differences in reductions in symptoms of anxiety were not statistically significant.CONCLUSIONS: The FAMOS intervention reduced parents' symptoms of PTSD and depression. Next step is to also report on psychological effects in the children and siblings (clinicaltrials.gov: NCT02200731).

KW - anxiety

KW - cancer

KW - cognitive behavioural psychotherapy

KW - depression

KW - family

KW - posttraumatic stress disorder

KW - randomised controlled trial

U2 - 10.1002/pbc.28853

DO - 10.1002/pbc.28853

M3 - Journal article

C2 - 33369038

VL - 68

SP - e28853

JO - Pediatric Blood and Cancer

JF - Pediatric Blood and Cancer

SN - 1545-5009

IS - 3

ER -

ID: 61822297